ZHANG, WENTING

USPTO Trademark & Patent Filings

Trademark applications and grants for Zhang, Wenting. Zhang, Wenting has 14 trademark applications. The latest application filed is for "BEKA"

Company Profile

Wenting Zhang
Zhang Wenting
Zhang, Wenting
wenting zhang
ZHANG; WENTING - WUHAN CN
Zhang; Wenting - Omaha NE
Zhang; Wenting - Kearny NJ
ZHANG; Wenting - Shenzhen Guangdong
Zhang; Wenting - Wuhan CN
Zhang; Wenting - Shanghai CN
Zhang; Wenting - Jersey City NJ
Zhang; Wenting - Sola NO

Entity Type	INDIVIDUAL
Address	ROOM 2518, BUILDING 3, PHASE 3, HUARUNCHENG RUNFU, NANSHAN DISTRICT, SHENZHEN CHINA 518000

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks Patents

Patent Applications

Patent Application	Date
HEAT-RESISTANT H1N1 SUBTYPE INFLUENZA VIRUS MUTANT STRAIN, PREPARATION METHOD AND APPLICATION THEREOF 20220096621 - 17/234785 SHANG; YU ; et al.	2022-03-31
HEAT-RESISTANT RECOMBINANT NEWCASTLE DISEASE VIRUS VACCINE STRAIN CAPABLE OF EXPRESSING TRUNCATED FIBER 2 PROTEIN OF FOWL ADENOVIRUS SEROTYPE 4, PREPARATION METHOD AND APPLICATION THEREOF 20220054626 - 17/234795 WEN; GUOYUAN ; et al.	2022-02-24
RADIOPHARMACEUTICALS AND METHODS OF USE THEREOF 20200316233 - 16/765507 Garrison; Jered ; et al.	2020-10-08
WELL PLATE-BASED PERFUSION CULTURE MODEL OF ENDOSTEAL-EXTRACELLULAR MATRIX (ECM)-AND ENDOTHELIAL-MYELOMA INTERACTIONS AND METHODS FOR TESTING PERSONALIZED THERAPEUTICS FOR MULTIPLE MYELOMA 20190055510 - 15/719737 Lee; Woo Young ; et al.	2019-02-21
METHOD AND SYSTEM FOR MEASURING AUDIO TRANSMISSION DELAY 20170005896 - 15/038861 ZOU; Lianping ; et al.	2017-01-05
Heat-resistant recombinant Newcastle Disease Virus vaccine strain capable of expressing truncated Fiber 2 protein of Fowl Adenovirus serotype 4, preparation method and application thereof 11,285,206 - 17/234,795 Wen , et al. March 29, 2	2022-03-29
Mat mounting structure in seat back and vehicle seat 11,273,743 - 17/129,989 Wilkinson , et al. March 15, 2	2022-03-15
Ex vivo human multiple myeloma cancer niche and its use as a model for personalized treatment of multiple myeloma 10,184,113 - 14/973,329 Lee , et al. Ja	2019-01-22
Microfluidic three-dimensional osteocyte network reconstructed with microbeads as scaffold 10,041,045 - 14/490,847 Lee , et al. August 7, 2	2018-08-07
Fibre composite rod petroleum well intervention cable 9,828,813 - 14/430,071 Zhang , et al. November 28, 2	2017-11-28

Patent Grants & Applications

Trademark Applications

Mark Image Registration \| Serial	Trademark Application Date
"BEKA" 98195101	BEKA 2023-09-25
"BEKA" 98195104	BEKA 2023-09-25
"BEKA" 98195109	BEKA 2023-09-25
"VIAGIA" 97314386	VIAGIA 2022-03-16
"SOEKELY" 97143055	SOEKELY 2021-11-25
"DOSCY" 97143052	DOSCY 2021-11-25
"PULEMS" 97143053	PULEMS 2021-11-25
"SIOTK" 97023973	SIOTK 2021-09-13
"DYNICT" 97008132	DYNICT 2021-09-02
"KDIYA" 97008208	KDIYA 2021-09-02
"HDH" 90832094	HDH 2021-07-16
"XFXS" 90832092	XFXS 2021-07-16
"PEXBEE" 90807473	PEXBEE 2021-07-01
"AMAZINGM" 88370564	AMAZINGM 2019-04-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.